Ordering Publications
To order a hard copy of any of the publications listed below from UCLA ISAP, send the article number (found at the end of the reference, for example "12.1"), the article author/title, and your postal address to:
Kris Langabeer
UCLA Integrated Substance Abuse Programs
1640 S. Sepulveda Blvd., Ste. 200
Los Angeles, CA 90025-7535
Your first 5 articles ordered per year are free, but additional articles are $1 per reprint. Checks should be made out to "UC Regents." Purchase orders will not be accepted for orders under $25.
Publications List (H-K)
(A list of all publications is available as an .rtf file).
Hall, E., Baldwin, D. M., & Prendergast, M. L. (2001). Women
on parole: barriers to success after substance abuse treatment.
Human Organization, 60(3), 225-233. (21.27)
Harlow, L. L., & Anglin, M. D. (1984). Time series design
to evaluate effectiveness of methadone maintenance intervention.
Journal of Drug Education, 14(1), 53-72. (10.5)
Hasson, A., Grella, C. E., Rawson, R., & Anglin, M. D. (1994).
Case management within a methadone maintenance program. A research
demonstration project for HIV risk reduction. Journal of Case
Management, 3(4), 167-172. (10.23)
Hegamin, A., Anglin, G., & Casanova, M. (2002). Deconstructing
the concept of "special populations". Journal of
Drug Issues, 32(3), 825-836. (13.35)
Hegamin, A., Anglin, G., & Farabee, D. (2000). Gender differences
in the perception of drug treatment: An examination of drug treatment
services delivered to California youth authority wards. UCLA DARC
White Paper. (15.9)
Hegamin, A., Anglin, G., & Farabee, D. (2001). Gender differences
in the perception of drug user treatment: assessing drug user
treatment for youthful offenders. Substance Use and Misuse,
36(14), 2159-2170. (14.08)
Hegamin, A., & Farabee, D. (2001). The utility of drug tests
and infraction data in evaluating youth correctional treatment.
Los Angeles: UCLA Drug Abuse Research Center. (13.29)
Hegamin, A., Farabee, D., & Monahan, G. (1999). Implementation
of the CYA-RSAT Programs. A process evaluation of the California
Youth Authority's Residential Substance Abuse Treatment (RSAT)
Programs (Year 2). Sacramento, CA: Office of Criminal Justice
Planning and The California Department of Youth Authority. (24.16)
Hegamin, A., Longshore, D., & Monahan, G. (2002). Health services
in correctional settings: Emerging issues and model strategies.
In: C. G. Leukefeld, F. M. Tims, & D. Farabee (Eds.), Treatment
of Drug Offenders: Policies and Issues (pp. 335-347). New
York: Springer Publishing Co. (03.27)
Henson, K. D., Longshore, D., Kowalewski, M. R., Anglin, M. D.,
& Annon, K. (1998). Perceived AIDS risk among adult arrestee
injection drug users in Los Angeles County. AIDS Education
and Prevention, 10(5), 447-464. (01.36)
Higgins, S. T., Roll, J. M., & Bickel, W. K. (1996). Alcohol
pretreatment increases preference for cocaine over monetary reinforcement.
Psychopharmacology, 123(1), 1-8. (27.8)
Hillhouse, M. P., & Fiorentine, R. (2001). 12-step program
participation and effectiveness: do gender and ethnic differences
exist? Journal of Drug Issues, 31(3), 767-780. (09.31)
Hoffman, V., & Anglin, M. D. (1997). Update on illicit drug
use in Los Angeles County. Paper presented at the semi-annual
meeting, Community Epidemiology Workgroup, Los Angeles, CA (08.5)
Hoffman, V., Annon, K., & Anglin, M. D. (1997). Update on
illicit drug use in Los Angeles County. Paper presented at the
semi-annual meeting, Community Epidemiology Workgroup, Los Angeles,
CA. (08.6)
Hoffman, V., & Bolton, R. (1997). Reasons for having sex and
sexual risk-taking: A study of heterosexual male STD clinic patients.
AIDS Care, 3, 285-296. (01.31)
Hoffman, V., & Cohen, D. (1999). A night with Venus: partner
assessments and high-risk sexual encounters. AIDS Care, 11(5),
555-566. (01.49)
Homer, J. B. (1993). Projecting the impact of law enforcement
on cocaine prevalence: A system dynamics approach. Journal
of Drug Issues, 23(2), 281-295. (12.19)
Homer, J. B. (1993). A system dynamics model for cocaine prevalence
estimation and trend projection. Journal of Drug Issues, 23(2),
251-279. (12.18)
Homer, J. B. (1990). A system dynamics simulation model of cocaine
prevalence. Unpublished manuscript, University of Southern California,
University of California, Los Angeles. (12.5)
Horti, A. G., Chefer, S. I., Mukhin, A. G., Koren, A. O., Gundisch,
D., Links, J. M., Kurian, V., Dannals, R. F., & London, E.
D. (2000). 6-[f-18]fluoro-a-85380, a novel radioligand for in
vivo imaging of central nicotinic acetylcholine receptors. Life
Sciences, 67(4), PL463-PL469. (30.14)
Horti, A. G., Koren, A. O., Lee, K. S., Mukhin, A. G., Vaupel,
D. B., Kimes, A. S., Stratton, M., & London, E. D. (1999).
Radiosynthesis and preliminary evaluation of 5-[i-123/125]iodo3-(2(s)-azetidinylmethoxy)pyridine:
a radioligand for nicotinic acetylcholine receptors. Nuclear
Medicine and Biology, 26(2), 175-182. (30.17)
Hser, Y. (1993). Data sources: Problems and issues. Journal
of Drug Issues, 23(2), 217-228. (12.16)
Hser, Y. (1995). Drug treatment counselor practices and effectiveness:
An examination of literature and relevant issues in a multilevel
framework. Evaluation Review, 19(4), 389-408. (18.41)
Hser, Y. (1993). Population estimates of intravenous drug users
and HIV infection in Los Angeles County. International Journal
of the Addictions, 28(8), 695-709. (01.10)
Hser, Y. (1993). Population estimation of illicit drug users in
Los Angeles County. Journal of Drug Issues, 23(2), 323-324.
(12.21)
Hser, Y. (1993). Prevalence estimation: Summary of common problems
and practical solutions. Journal of Drug Issues, 23(2),
335-343. (12.22)
Hser, Y. (1995). A referral system that matches drug users to
treatment programs: Existing research and relevant issues.
Journal of Drug Issues, 25(1), 209-224. (18.36)
Hser, Y. (1997). Self-reported drug use: Results of selected empirical
investigations of validity. In: L. Harrison, & A. Hughes (Eds.),
The validity of self-reported drug use: Improving the accuracy
of survey estimates (NIDA Research Monograph 167, pp. 320-343).
Rockville, MD: National Institute on Drug Abuse. (13.14)
Hser, Y., & Anglin, M. D. (2002). Book review [Review of the
book Making research relevent and beyond. Bridging the gap
between practice and research: Forging partnerships with community-based
drug and alcohol treatment]. Contemporary Psychology:
APA Review of Books, 47(1). (13.31)
Hser, Y., & Anglin, M. D. (1991). Cost-effectiveness of drug
abuse treatment: Relevant issues and alternative longitudinal
modeling approaches. In: W. S. Cartwright, & J. M. Kaple (Eds.),
Economic costs, cost-effectiveness, financing, and community-based
drug treatment (NIDA Research Monograph 113, pp. 67-93).
Rockville, MD: National Institute on Drug Abuse. (18.20)
Hser, Y., & Anglin, M. D. (1992). A multi-method approach
for estimating numbers of illicit drug users. In: Resource
materials for state needs assessment studies (pp. 33-54).
Washington, DC: Office for Treatment Improvement. (12.9)
Hser, Y., & Anglin, M. D. (1992). Patterns and consequences
of narcotics addiction, final report. Washington, DC: National
Institute on Drug Abuse. (03.9)
Hser, Y., Anglin, M. D., & Booth, M. W. (1987). Sex differences
in addict careers. 3. Addiction. American Journal of Drug
And Alcohol Abuse, 13(3), 231-251. (14.5)
Hser, Y., Anglin, M. D., & Chou, C. P. (1988). Evaluation
of drug abuse treatment: A repeated measures design assessing
methadone maintenance. Evaluation Review, 12(5), 547-570.
(18.8)
Hser, Y., Anglin, M. D., & Chou, C. P. (1991). Narcotics use
and crime among addicted women: Longitudinal patterns and effects
of social interventions. In: T. Mieczkowski (Ed.), Drugs,
crime, and social policy: Research, issues, and concerns
(pp. 197-221). Boston: Allyn and Bacon. (21.4)
Hser, Y., Anglin, M. D., & Chou, C. P. (1992). Reliability
of retrospective self-report by narcotics addicts. Psychological
Assessment, 4(2), 207-213. (12.10)
Hser, Y., Anglin, M. D., & Fletcher, B. W. (1998). Comparative
treatment effectiveness: Effects of program modality and client
drug dependence history on drug use reduction. Journal of
Substance Abuse Treatment, 15(1), 1-11. (24.1)
Hser, Y., Anglin, M. D., Grella, C. E., Longshore, D., & Prendergast,
M. L. (1997). Drug treatment careers: A conceptual framework and
existing research findings. Journal of Substance Abuse Treatment,
14(6), 543-558. (18.55)
Hser, Y., Anglin, M. D., & Liu, Y. (1990-1991). A survival
analysis of gender and ethnic differences in responsiveness to
methadone maintenance treatment. International Journal of
the Addictions, 25(11A), 1295-1315. (09.3)
Hser, Y., Anglin, M. D., & McGlothlin, W. H. (1987). Sex differences
in addict careers. 1. Initiation of use. American Journal
of Drug and Alcohol Abuse, 13(1-2), 33-57. (14.6)
Hser, Y., Anglin, M. D., & Powers, K. I. (1993). A 24-year
follow-up of California narcotics addicts. Archives of General
Psychiatry, 50(7), 577-584. (03.8)
Hser, Y., Anglin, M. D., & Powers, K. I. (1990). Longitudinal
patterns of alcohol use by narcotic addicts. In: M. Galanter (Ed.),
Recent developments in alcoholism, Vol. III: Combined alcohol
and other drug dependencies (pp. 145-171). New York: Plenum
Press. (02.5)
Hser, Y., Anglin, M. D., Wickens, T. D., Brecht, M. L., &
Homer, J. B. (1992). Techniques for the estimation of illicit
drug-use prevalence: An overview of relevant issues. Washington,
DC: National Institute of Justice. (12.11)
Hser, Y., Boyle, K., & Anglin, M. D. (1998). Drug use and
correlates among STD patients, ER patients, and arrestees. Journal
of Drug Issues, 28(2), 437-453. (20.6)
Hser, Y., Chou, C. P., & Anglin, M. D. (1990). The criminality
of female narcotics addicts: A causal modeling approach. Journal
of Quantitative Criminology, 6(2), 207-228. (21.3)
Hser. Y., Chou, C. P., Hoffman, V., & Anglin, M. D. (1999).
Cocaine use and high-risk sexual behavior among STD clinic patients.
Sexually Transmitted Diseases, 26(2), 82-86. (04.32)
Hser, Y., Grella, C. E., Chou, C. P., & Anglin, M. D. (1998).
Relationships between drug treatment careers and outcomes: Findings
from the National Drug Abuse Treatment Outcome Study. Evaluation
Review, 22(4), 496-519. (18.64)
Hser, Y., Grella, C. E., Hsieh, S., Anglin, M. D., & Brown,
B. S. (1999). Prior treatment experience related to process and
outcomes in DATOS. Drug and Alcohol Dependence, 57(2),
137-150. (18.80)
Hser, Y., Grella, C. E., Hubbard, R. L., Hsieh, S., Fletcher,
B. W., Brown, B. S., & Anglin, M. D. (2001). An evaluation
of drug treatments for adolescents in 4 US cities. Archives
of General Psychiatry, 58, 689-695. (25.1)
Hser. Y., Hoffman, V., Grella, C. E., & Anglin, M. D. (2001).
A 33-year follow-up of narcotics addicts. Archives of General
Psychiatry, 58, 503-508. (03.11)
Hser. Y., Joshi, V., Anglin, M. D., & Fletcher, B. W. (1999).
Predicting posttreatment cocaine abstinence for first-time admissions
and treatment repeaters. American Journal of Public Health,
89(5), 666-671. (04.33)
Hser, Y., Joshi, V., Maglione, M. A., Chou, C. P., & Anglin,
M. D. (2001). Effects of program and patient characteristics on
retention of drug treatment patients. Evaluation and Program
Planning, 24(4), 331-341. (13.22)
Hser, Y., Longshore, D., & Anglin, M. D. (1994). Prevalence
of drug use among criminal offender populations: Implications
for control, treatment, and policy. In: D. L. MacKenzie, &
C. D. Uchida (Eds.), Drugs and the criminal justice system:
Evaluating public policy initiatives (pp. 18-41). Thousand
Oaks, CA: Sage Publications. (06.16)
Hser, Y., Maglione, M. A., & Boyle, K. (1999). Validity of
self-report of drug use among STD patients, ER patients, and arrestees.
American Journal of Drug and Alcohol Abuse, 25(1), 81-91.
(20.7)
Hser, Y., Maglione, M. A., Polinsky, M. L., & Anglin, M. D.
(1997). Predicting treatment entry among treatment-seeking drug
abusers. Journal of Substance Abuse Treatment, 15(3),
213-220. (18.51)
Hser, Y., McCarthy, W. J., & Anglin, M. D. (1994). Tobacco
use as a distal predictor of mortality among long-term narcotics
addicts. Preventive Medicine, 23(1), 61-69. (17.2)
Hser, Y., Polinsky, M. L., Maglione, M. A., & Anglin, M. D.
(1999). Matching client's needs with drug treatment services.
Journal of Substance Abuse Treatment, 16(4), 299-305.
(24.2)
Hser, Y., Prendergast, M. L., Anglin, M. D., Chen, J., & Hsieh,
S. (1998). A regression analysis estimating the number of drug
using arrestees in 185 U.S. cities. American Journal of Public
Health, 88(3), 487-490. (06.26)
Hser. Y., Shen, H., Chou, C. P., Messer, S. C., & Anglin,
M. D. (2001). Analytic approaches for assessing long-term treatment
effects. Evaluation Review, 25(2), 233-262. (18.93)
Hser. Y., Shen, H., Grella, C. E., & Anglin, M. D. (1999).
Lifetime severity index for cocaine use disorder (LSI-Cocaine).
Journal of Nervous and Mental Disease, 187(12), 742-750.
(04.38)
Hser, Y., Stein, J. A., Maglione, M. A., & Polinsky, M. L.
(1998). Predicting perceived quality of drug treatment programs
using latent variable models. Evaluation and Program Planning,
21(1), 1-10. (18.54)
Hser, Y., & Yamaguchi, K. (1994). Relapse to narcotics addiction:
An event-history analysis of intervention effects. Paper presented
at the Proceedings of the 1993 annual meeting, American Statistical
Association: (03.10)
Hser, Y., Yamaguchi, K., Chen, J., & Anglin, M. D. (1995).
Effects of interventions on relapse to narcotics addiction: An
event-history analysis. Evaluation Review, 19(2), 123-140.
(18.27)
Hser Y.I., Grella C.E., Collins, C., & Teruya, C. (2003).
Drug-use initiation and conduct disorder among adolescents in
drug treatment. Journal of Adolescence, 26, 331-345.
(05.22)
Huba, G. J. (1990). From theory to practice: The planned treatment
of drug users. International Journal of the Addictions, 25(4),
445-469. (18.15)
Huber, A., Ling, W., Shoptaw, S., Gulati, V., Brethen, P., &
Rawson, R. (1997). Integrating treatments for methamphetamine
abuse: A psychosocial perspective. Journal of Addictive Diseases,
16(4), 41-50. (18.56)
Huber, A., Lord, R. H., Gulati, V., Marinelli-Casey, P., Rawson,
R., & Ling, W. (2000). The CSAT methamphetamine treatment
program: research design accommodations for "real world"
application. Journal of Psychoactive Drugs, 32(2), 149-156.
(28.21)
Hunt, D. E. (1987). Crack. Los Angeles: Drug Abuse Information
and Monitoring Project, UCLA Drug Abuse Research Center. (04.3)
Isralowitz, R., Sussman, G., Afifi, M., Rawson, R., Babor, T.,
& Monteiro, M. (2001). Substance abuse policy and peace in
the Middle East: a Palestinian and Israeli partnership. Addiction,
96, 973-980. (18.107)
Issari, P., & Coombs, R. H. (1998). Women, drug use, and drug
testing. Journal of Sport and Social Issues, 22(2), 153-169.
(21.23)
Jarvik, M. E. (1990). The drug dilemma: Manipulating the demand.
Science, 250, 387-392. (13.9)
Johnson, B. A., Jasinski, D. R., Galloway, G. P. , Kranzler, H.,
Weinreib, R., Anton, R. F., Mason, B. J., Bohn, M. J., Pettinati,
H. M., Rawson, R., & Clyde, C. (1996). Ritanserin in the treatment
of alcohol dependence -- a multi-center clinical trial. Psychopharmacology,
128, 206-215. (02.18)
Johnson, P. B., Boles, S. M., & Kleber, H. D. (2000). The
relationship between adolescent smoking and drinking and likelihood
estimates of illicit drug use. Journal of Addictive Diseases,
19(2), 75-81. (05.6)
Johnson, P. B., Boles, S. M., Kleber, H. D., Vaughan, R., &
McVeigh, K. H. (2000). Age-related differences in adolescent smokers'
and nonsmokers' assessments of the relative addictiveness and
health harmfulness of cigarettes, alcohol, and marijuana. Journal
of Substance Abuse Treatment, 11(1), 45-52. (05.5)
Johnson, P. B., Boles, S. M., Vaughan, R., & Kleber, H. D.
(2000). The co-occurrence of smoking and binge drinking in adolescence.
Addictive Behaviors, 25(5), 779-783. (05.7)
Joshi, V., Grella, C. E., & Hser, Y. (2001). Drug use and
treatment initiation patterns: Differences by birth-cohorts. Journal
of Drug Issues, 31(4), 1039-1062. (13.21)
Joshi, V., Hser, Y., Grella, C. E., & Houlton, R. (2001).
Sex-related HIV risk reduction behavior among adolescents in DATOS-A.
Journal of Adolescent Research, 16(6), 642-660. (05.10)
Johnson, R. E., Strain, E. C., & Amass, L. (2003). Buprenorphine:
How to use it right. Drug and Alcohol Dependence, 20(2,
Suppl.1), S59-S77. (29.24)
Kalechstein, A., Newton, T., & Leavengood, A. H. (2002). Apathy
syndrome in cocaine dependence. Psychiatry Research, 109(1),
97-100. (04.15)
Kalechstein, A., Newton, T., Longshore, D., Anglin, M. D., Van
Gorp, W. G., & Gawin, F. H. (2000). Psychiatric comorbidity
of methamphetamine dependence in a forensic sample. Journal
of Neuropsychiatry and Clinical Neurosciences, 12(4), 480-484.
(28.5)
Kamien, J. B., Bickel, W. K., Smith, B. J., Badger, G. J., &
Hughes, J. R. (1997). Secobarbital in humans discriminating triazolam
under two-response and novel-response procedures. Pharmacology,
Biochemistry and Behavior, 58(4), 983-991. (13.25)
Kasarabada, N. D., Anglin, M. D., Khalsa-Denison, M. E., &
Paredes, A. (1997). Cocaine, crime, family history of deviance--Are
psychosocial correlates related to these phenomena in male cocaine
users? Unpublished manuscript, University of California, Los Angeles,
Drug Abuse Research Center: (04.31)
Kasarabada, N. D., Anglin, M. D., Khalsa-Denison, M. E., &
Paredes, A. (1999). Differential effects of treatment modality
on psychosocial functioning of cocaine-dependent men. Journal
of Clinical Psychology, 55(2), 257-274. (04.29)
Kasarabada, N. D., Anglin, M. D., Khalsa-Denison, M. E., &
Paredes, A. (1998). Variations in psychosocial functioning associated
with patterns of progression in cocaine-dependent men. Addictive
Behaviors, 23(2), 179-189. (04.34)
Kasarabada, N. D., Hser, Y., Boles, S. M., & Huang, Y. C.
(2002). Do patients' perceptions of their counselors influence
outcomes of drug treatment? Journal of Substance Abuse Treatment,
23, 327-334. (18.104)
Kasarabada, N. D., Hser, Y., Parker, L. E., Hall, E., Anglin,
M. D., & Chang, E. (2001). A self-administered instrument
for assessing therapeutic approaches of drug-user treatment counselors.
Substance Use and Misuse, 36(3), 273-299. (13.23)
Katz, D. (1991). Geriatric use and misuse of medications. Los
Angeles: Drug Abuse Information and Monitoring Project, UCLA Drug
Abuse Research Center. (07.1)
Khalsa-Denison, M. E., Paredes, A., & Anglin, M. D. (1995).
Correlates of post-treatment cocaine use reduction. (NIDA
Research Monograph). Rockville, MD: National Institute on Drug
Abuse. (04.5)
Khalsa-Denison, M. E., Paredes, A., & Anglin, M. D. (1995).
A natural history assessment of cocaine dependence: Pre-and
post-treatment behavioral patterns. (NIDA Research Monograph).
Rockville, MD: National Institute on Drug Abuse. (04.27)
Khalsa, H. K., & Anglin, M. D. (1990). Substance abuse among
the mentally ill: Developing treatment alternatives. Unpublished
manuscript, University of California, Los Angeles, Drug Abuse
Research Center. (15.2)
Khalsa, H. K., Anglin, M. D., & Paredes, A. (1992). Cocaine
abuse: Outcomes of therapeutic interventions. Substance Abuse,
13(4), 165-179. (04.11)
Khalsa, H. K., Kowalewski, M. R., Anglin, M. D., & Wang, J.
C. (1992). HIV-related risk behaviors among cocaine users. AIDS
Education and Prevention, 4(1), 71-83. (01.11)
Khalsa, H. K., Paredes, A., & Anglin, M. D. (1992). The role
of alcohol in cocaine dependence. In: M. Galanter (Ed.), Recent
developments in alcoholism, Vol. 10: Alcohol and cocaine: Similarities
and differences (pp. 7-35). New York: Plenum Press. (02.6)
Khalsa, H. K., Shaner, A., Anglin, M. D., & Wang, J. C. (1991).
Prevalence of substance abuse in a psychiatric evaluation unit.
Drug and Alcohol Dependence, 28(3), 215-223. (12.7)
Khalsa, M. E., & Anglin, M. D. (1991). Treatment effectiveness
for cocaine abuse. In: United Nations Interregional Crime and
Research Institute, Monograph Cocaine today and it's effects
on the individual and society (pp. 89-98). UNICRI Publication
No. 44. (18.17)
Khalsa, M. E., Anglin, M. D., Paredes, A., Potepan, P., &
Potter, C. (1993). Pretreatment natural history of cocaine addiction:
Preliminary 1-year follow-up results. In: F. M. Tims, & C.
G. Leukefeld (Eds.), Cocaine treatment: Research and clinical
perspectives (NIDA Research Monograph 135, pp. 218-236).
Rockville, MD: National Institute on Drug Abuse. (18.16)
Khalsa, M. E., Kowalewski, M. R., Lunn, R., Anglin, M. D., &
Miller, K. A. (1994). AIDS-related knowledge, beliefs and risk
behaviors in a sample of crack addicts. Journal of Drug Issues,
24(3), 537-553. (01.18)
Khalsa, M. E., Miller, K. A., & Anglin, M. D. (1992). Cocaine-related
problems as influences in patterns of cocaine use. (NIDA
Research Monograph ). Rockville, MD: National Institute on Drug
Abuse. (04.19)
Khalsa, M. E., Paredes, A., & Anglin, M. D. (1993). Cocaine
dependence: Behavioral dimensions and patterns of progression.
American Journal on Addictions, 2(4), 330-345. (04.13)
Khalsa, M. E., Paredes, A., Anglin, M. D., Potepan, P., &
Potter, C. (1993). Combinations of treatment modalities and therapeutic
outcome for cocaine dependence. In: F. M. Tims, & C. G. Leukefeld
(Eds.), Cocaine treatment: Research and clinical perspectives
(NIDA Research Monograph 135, pp. 237-259). Rockville, MD: National
Institute on Drug Abuse. (04.26)
Khalsa, M. E., Tashkin, D. P., & Perrochet, B. (1992). Smoked
cocaine: Patterns of use and pulmonary consequences. Journal
of Psychoactive Drugs, 24(3), 265-272. (04.8)
Kimes, A. S., Horti, A. G., London, E. D., Chefer, S. I., Contoreggi,
C., Ernst, M., Friello, P., Koren, A. O., Kurian, V., Matochik,
J. A., Pavlova, O. A., Vaupel, D. B., & Mukhin, A. G. (2003).
2-[18F]F-A85380: PET imaging of brain nicotinic acetylcholine
receptors and whole body distribution in humans. FASEB Journal,
(30.23)
Kimes, A. S., Maldonado, R., Ambrosio, E., Koob, G. F., &
London, E. D. (1998). Cerebral glucose metabolism during opioid
withdrawal following methylnaloxonium injection into the locus
coeruleus. Brain Research, 814(1-2), 1-12. (30.1)
Kirkish, P., Sreenivasan, S., Welsh, R. K., Van Gorp, W. G., Eth,
S., Shoptaw, S., & Ling, W. (2000). The future of criminal
violence: juveniles tried as adults. Journal of the American
Academy of Psychiatry and the Law, 28(1), 38-46. (06.38)
Koren, A. O., Horti, A. G., Mukhin, A. G., Gundisch, D., Dannals,
R. F., & London, E. D. (2000). Synthesis and initial in vitro
characterization of 6-[f-18]fluoro-3-(2(s)-azetidinylmethoxy)pyridine,
a high-affinity radioligand for central nicotinic acetylcholine
receptors. Journal of Labelled Compounds and Radiopharmaceuticals,
43(5), 413-423. (30.13)
Kowalewski, M. R., Henson, K. D., & Longshore, D. (1997).
Rethinking perceived risk and health behavior: A critical review
of HIV prevention research. Health Education and Behavior,
24(3), 313-325. (01.30)
Kowalewski, M. R., Khalsa, H. K., Anglin, M. D., & Cason,
G. (1991). Assessment of HIV seroprevalence and behavior risk
among cocaine users. Substance Abuse, 13(4), 180-187.
(01.7)
Kowalewski, M. R., Longshore, D., & Anglin, M. D. (1994).
The AIDS risk reduction model: Examining intentions to use condoms
among injection drug users. Journal of Applied Social Psychology,
24(22), 2002-2027. (01.20)
Kronstadt, D. (1991). Issues of alcohol and drug use during pregnancy:
Identifying and intervening with pregnant women. Los Angeles:
Drug Abuse Information and Monitoring Project, UCLA Drug Abuse
Research Center. (21.5)
Last updated - 02/11/2010